Status:
COMPLETED
Acupuncture for the Treatment of Rheumatoid Arthritis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To study the efficacy of acupuncture used as an adjunct measure for patients with refractory RA
Detailed Description
The study employs a randomized, prospective, double-blind, placebo-controlled trial to evaluate the effect of electroacupuncture, traditional Chinese acupuncture and sham acupuncture in patients with ...
Eligibility Criteria
Inclusion
- Fulfilled The American College of Rheumatology (ACR)\[10\] criteria of RA
- Active disease affecting the hands and wrists defined as having at least 4 tender joints and 2 swollen joints
- Early morning stiffness of greater than 45 minutes
- ESR \> 28 mmHg or CRP \> 10
- Patients taking disease modifying anti-rheumatic drugs (DMARDs) were eligible if they were on a stable dose for at least 3 months before screening.
- Patients on stable doses of one non-steroidal anti-inflammatory drug (NSAID) or up to 10 mg daily prednisone were also included.
Exclusion
- Under the age of 18 years
- Pregnancy
- Previously had acupuncture
- Localized skin infections
- Anticoagulated
- Bleeding diathesis
- Intra-articular corticosteroid within 4 weeks preceding the study
- Any severe chronic or uncontrolled co-morbid disease
- Fear of needles
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00404443
Start Date
December 1 2004
End Date
January 1 2006
Last Update
May 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Institute of Chinese Medicine
Hong Kong, China